2084-P: Sustained Weight Loss in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study

Sustained Weight Loss ◽

Improvement of Type 2 Diabetes (T2DM) and Reduction of Major Adverse Cardiovascular Events and Mortality in Hypogonadal Men Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU)—Real-Life Evidence from a Urological Registry Study

Diabetes ◽

10.2337/db18-111-lb ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 111-LB

Author(s):

FARID SAAD ◽

KARIM S. HAIDER ◽

AHMAD HAIDER

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Events ◽

Real Life ◽

Term Treatment ◽

Major Adverse Cardiovascular Events ◽

Registry Study ◽

178-OR: Long-Term Treatment with Injectable Testosterone Undecanoate (TU) Improves Lipid Profile in Men with Hypogonadism and Type 2 Diabetes in Comparison to an Untreated Control Group: Ten-Year Data from a Urological Registry Study

Diabetes ◽

10.2337/db19-178-or ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 178-OR

Author(s):

FARID SAAD ◽

KARIM S. HAIDER ◽

AHMAD HAIDER

Keyword(s):

Type 2 Diabetes ◽

Untreated Control ◽

Term Treatment ◽

Control Group ◽

Registry Study ◽

Untreated Control Group ◽

Review for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v2/review2 ◽

2020 ◽

Author(s):

Kuat Oshakbayev

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

Author response for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v2/response1 ◽

2020 ◽

Author(s):

Karim Sultan Haider ◽

Ahmad Haider ◽

Farid Saad ◽

Gheorghe Doros ◽

Markolf Hanefeld ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Author Response ◽

Registry Study ◽

Review for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v2/review3 ◽

2020 ◽

Author(s):

Thomas Jones

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

1123-P: Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study

Diabetes ◽

10.2337/db19-1123-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1123-P

Author(s):

KARIM S. HAIDER ◽

AHMAD HAIDER ◽

FARID SAAD

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Events ◽

Term Treatment ◽

Major Adverse Cardiovascular Events ◽

Registry Study ◽

Long Term Treatment ◽

Reduction Of Mortality

Decision letter for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v3/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

Review for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v1/review5 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

Decision letter for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽

Review for "Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study"

10.1111/dom.14122/v1/review1 ◽

2020 ◽

Author(s):

Thomas Jones

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Treatment ◽

Registry Study ◽